
NEONC TECHNOLOGIES HOLDINGS, INC. — Investor Relations & Filings
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company that has developed a proprietary, patented platform technology for transporting therapeutics directly to the brain. Its core innovation is an intranasal drug delivery system designed to overcome the limitations of the Blood-Brain Barrier (BBB), enabling more effective treatment for Central Nervous System (CNS) diseases. The company's primary focus is on developing novel therapies for brain cancers, such as glioblastoma, with pipeline candidates including NEO100 and NEO212. The platform is also designed to facilitate the transport of established and new third-party therapeutics, aiming to improve efficacy for a wide range of brain-related conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-16 | English | |
| 424B5 - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-16 | English | |
| S-3 - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-10 | English | |
| 8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-10 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DiaMedica Therapeutics Inc.
Clinical-stage biopharma developing therapies for ischemic …
|
DMAC | US | Manufacturing |
|
Diamyd Medical AB (publ)
A clinical-stage company developing precision therapies for…
|
DMYD | SE | Manufacturing |
|
Diasorin
A global leader in In Vitro Diagnostics for immunodiagnosti…
|
DIA | IT | Manufacturing |
|
Dicot Pharma AB
Develops a potency agent for erectile dysfunction and prema…
|
DICOTBT | SE | Manufacturing |
|
Digicann Ventures Inc.
Manufacturer and distributor of medical cannabis products a…
|
DCNN | CA | Manufacturing |
|
Disc Medicine, Inc.
Clinical-stage biopharma developing therapies for serious h…
|
IRON | US | Manufacturing |
|
Discover Wellness Solutions Inc
Licensed producer and processor of cannabis products focuse…
|
WLNS | CA | Manufacturing |
|
Dishman Carbogen Amcis Limited
Global CDMO providing integrated API development and manufa…
|
DCAL | IN | Manufacturing |
|
Divi's Laboratories Ltd.
Manufacturer of APIs and intermediates specializing in CRAM…
|
DIVISLAB | IN | Manufacturing |
|
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Biopharmaceutical company developing innovative cancer and …
|
688192 | CN | Manufacturing |
NEONC TECHNOLOGIES HOLDINGS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33805/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33805 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33805 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33805 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33805}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NEONC TECHNOLOGIES HOLDINGS, INC. (id: 33805)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.